Insider Trading History of Cawkwell Gail

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Cawkwell Gail since 2019. This trader's CIK number is 1761167. At the time of last reporting, Cawkwell Gail was the Chief Medical Officer of Aclaris Therapeutics, Inc.. (stock ticker symbol ACRS). Also see all insider trading activities at Aclaris Therapeutics, Inc..

Note that in the past Cawkwell Gail also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Intercept Pharmaceuticals, Inc. (ICPT) by Cawkwell Gail

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 ICPT 0 $0 54 $6,750 1,884 $102,922
2019 ICPT 0 $0 262 $32,750 262 $14,313

Yearly summary of insider trading at Aclaris Therapeutics, Inc. (ACRS) by Cawkwell Gail

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 ACRS 0 $0 0 $0 15,000 $0


Insider trading activities at 2 companies by Cawkwell Gail:

1. Intercept Pharmaceuticals, Inc. (ICPT)

2. Aclaris Therapeutics, Inc. (ACRS)

Table 1. Insider trading of Intercept Pharmaceuticals, Inc. (ICPT) by Cawkwell Gail

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-12-31 ICPT Sale 262 125.00 32,750
2019-12-31 ICPT Option Ex 262 54.63 14,313
2019-12-26 ICPT Sale 54 125.00 6,750
2019-12-26 ICPT Option Ex 54 54.63 2,950
2019-12-03 ICPT Option Ex 80 54.63 4,370
2019-04-18 ICPT Option Ex 1,750 54.63 95,602

Table 2. Insider trading of Aclaris Therapeutics, Inc. (ACRS) by Cawkwell Gail

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-07-01 ACRS Option Ex 15,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cawkwell Gail (Chief Medical Officer of Aclaris Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.